Intarcia Therapeutics Stock

intarcia.comHealthcare / BioTech & PharmaFounded: 1995Funding to Date: $961.46MM

Intarcia is a biotech company dedicated to redesigning the treatment, prevention and experience of chronic disease.

Register To Buy and Sell Shares

For more details on financing and valuation for Intarcia Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Intarcia Therapeutics’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Intarcia Therapeutics.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

Team

Management Team

Paul Feldman, Ph.D.
Head of Discovery and Translational Medicine
David Spellman
Chief Business Officer and Chief Financial Officer
Thomas Alessi, Ph.D.
Vice President, Development and Manufacturing
Fred Fiedorek, M.D.
Chief Medical Officer and Global Head of Regulatory Affairs
Raymond Keane
Chief Legal Officer
Thane Wettig
Chief Commercial Officer
Jay Smith
Chief Experience Officer
Kurt Graves
Chairman, President & Chief Executive Officer
Anders Vinther, Ph.D
Global Head of Technical Operations
James Brady
Vice President, Human Resources
Andrew Young, M.B., Ch.B. (M.D.), Ph.D.
Chief Scientific Officer

Board Members

Bryan Roberts, Ph.D.
Venrock
Patrick Conway, MD
Kurt Graves
Nancy Thornberry
Bob Kerrey
Gino Santini
Jay S. Skyler, MD, MACP
Jim Rosenthal

News Highlights

Diabetic Therapeutic Market Size, Application,Revenue, Types, Trends in Future, Scope to 2021 - TokensJournal
The Diabetic Therapeutic Market  report  provides valuable and unique information which is very  essential. Further it also covers key players,application and future market condition.This information is extremely useful information for new and growing  company to mark themself over the market Diabetic Therapeutic market to grow at a CAGR OF 7.55% during the period 2017-2021. This …
The 25 most valuable private tech companies in the US
Tech companies are continuing to garner major venture capital investment in 2018. Here are the 25 most valuable VC-backed startups in the US.
Global Diabetic Therapeutic Market 2021 Evolution Production Analysis by Price, Revenue, Cost and Gross Margin - BitsEther
Diabetic Therapeutic Market report evaluate the current opportunity and the future potential of the Diabetic Therapeutic market over the coming decade. Based on various parameters, Diabetic Therapeutic Market provides complete analysis of manufacturers, suppliers, distributors, traders, customers, major types and applications. “The global diabetic therapeutic market is growing at a high pace owing to the …
Updated on: May 17, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.